BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2555002)

  • 21. Immunoprophylaxis with anti D immunoglobulins in Rh negative women.
    Gupta I; Jolly JG; Gupta AN
    Indian J Med Res; 1987 Jun; 85():656-8. PubMed ID: 2824352
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-D immunoglobulin prophylaxis--are we doing enough?
    Drug Ther Bull; 1985 Dec; 23(24):93-5. PubMed ID: 2998720
    [No Abstract]   [Full Text] [Related]  

  • 23. Antenatal Rh immunoglobulin--help or hindrance?
    Pisciotto P; Gorbants I; Sundra M
    Transfusion; 1985; 25(1):88. PubMed ID: 2982225
    [No Abstract]   [Full Text] [Related]  

  • 24. Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.
    Koelewijn JM; de Haas M; Vrijkotte TG; van der Schoot CE; Bonsel GJ
    BJOG; 2009 Sep; 116(10):1307-14. PubMed ID: 19538414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economics of antenatal prophylaxis.
    Cairns JA
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():19-22. PubMed ID: 9863974
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention of D isoimmunization. ACOG Technical Bulletin number 147--October 1990.
    Int J Gynaecol Obstet; 1992 Jan; 37(1):53-6. PubMed ID: 1346604
    [No Abstract]   [Full Text] [Related]  

  • 27. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 28. [Promotion of immunization against Rh D antigen following early administration of IgG anti-D during pregnancy?].
    Huchet J; Brossard Y
    Rev Fr Transfus Immunohematol; 1988 Feb; 31(1):65-9. PubMed ID: 2840729
    [No Abstract]   [Full Text] [Related]  

  • 29. Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis.
    Lee D
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9596614
    [No Abstract]   [Full Text] [Related]  

  • 30. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists.
    Lee D; Contreras M; Robson SC; Rodeck CH; Whittle MJ
    Transfus Med; 1999 Mar; 9(1):93-7. PubMed ID: 10216910
    [No Abstract]   [Full Text] [Related]  

  • 31. Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures.
    Bowman JM; Pollock JM
    Transfus Med Rev; 1987 Aug; 1(2):101-12. PubMed ID: 2856541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rate of RhD sensitisation before and after implementation of a community based antenatal prophylaxis programme.
    Mayne S; Parker JH; Harden TA; Dodds SD; Beale JA
    BMJ; 1997 Dec; 315(7122):1588. PubMed ID: 9437277
    [No Abstract]   [Full Text] [Related]  

  • 33. The prevention of Rh haemolytic disease of the fetus and newborn--general background.
    Contreras M
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():7-10. PubMed ID: 9863972
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

  • 35. Implementation of NICE recommendation for a policy of routine antenatal anti-D prophylaxis: a survey of UK maternity units.
    Harkness M; Freer Y; Prescott RJ; Warner P
    Transfus Med; 2008 Oct; 18(5):292-5. PubMed ID: 18937736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative analysis of the effects to date of the prevention of Rh incompatibility].
    Jedwabny A; Suchocki S; Bobrowska G
    Acta Haematol Pol; 1988; 19(1-2):56-8. PubMed ID: 2853507
    [No Abstract]   [Full Text] [Related]  

  • 37. Why women are not receiving anti-Rh prophylaxis.
    Hussey RM
    Br Med J (Clin Res Ed); 1987 Jan; 294(6564):119. PubMed ID: 3032323
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-D immunoglobulin in RhD prophylaxis.
    Robson SC; Lee D; Urbaniak S
    Br J Obstet Gynaecol; 1998 Feb; 105(2):129-34. PubMed ID: 9501773
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hemolytic disease of the newborn has not vanished from Finland--routine protection of RhD negative mothers during pregnancy is justifiable].
    Sainio S; Kuosmanen M
    Duodecim; 2012; 128(2):151-7. PubMed ID: 22372070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists Consensus Conference on anti-D prophylaxis, 7-8 April 1997.
    Br J Haematol; 1997 Jun; 97(4):927-8. PubMed ID: 9217199
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.